EUCTR2006-001045-34-IT进行中（未招募）不适用
Metronomic chemiotherapic treatment WITH IRINOTECAN Cpt-11 IN PATIENTS WITH metastatic colon-rectal cancer PHARMACODYNAMIC And PHARMACOKINETIC evaluation. - CPTTS Study
AZIENDA USL 6 LIVORNO ZONA LIVORNESE0 个研究点目标入组 18 人开始时间: 2006年3月14日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Age 18 years ECOG PS to 2 istologic Diagnoses of colorectal cancer with not resecabile metastatic disease Previous comprising treatments for the metastatic disease Cpt-11, L-ohp and 5-fu/lv or contraindication to theirs I use measurable or valued Disease Attended of life at least 3 months Adapted renal functionality creatinine 1,25 V.N. Adapted hepatic functionality bil. tot. 1,5 V.N., PAL 2,5 V.N., SGOT and SGPT 5 V.N. Adapted medullary functionality GB 3000 x 109/L, PLT 100,000 x 109/L, Hgb 10 g/dL informed Consent written Last finished chemioterapic or radioterapic treatment from at least 4 weeks
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Encefalic metastases Crohn disease, other inflammatory disease of the intestine Colectomia total or ileostomia Occlusion or internal sub-occlusion scompensate metabolic Diseases or infections in action cardiac Arrhythmies or ischemic cardiopathy not controlled Impossibility to execute adequate follow-up a Pregnancy upgrades them or in action Breast-feeding Second neoplasma
研究者
相似试验
已完成
1 期
A phase I/II study of chemotherapy using Irinotecan, S-1 plus Oxaliplatin (IRISOX therapy) for unresectable pancreatic cancerJPRN-UMIN000016945Department of Gastroenterology Kitasato University School of Medicine25
招募中
不适用
A I/II phase study of chemotherapy using irinotecan plus L-OHP plus S-1 treatment (SOXIRI) for unresectable advanced pancreatic cancerunresectable advanced pancreatic cancerJPRN-UMIN000012975the university of tokushima30
进行中（未招募）
1 期
Metronomic chemotherapy in elderly non-fit patients with aggressive B-Cell lymphomas. Phase II studyB-Cell lymphomasMedDRA version: 21.0Level: LLTClassification code 10012855Term: Diffuse large cell lymphoma (Diffuse large B-cell lymphoma) (Working Formulation)System Organ Class: 100000004864EUCTR2016-003703-62-ITFONDAZIONE ITALIANA LINFOMI ONLUS60
招募中
不适用
A feasibility study of the metronomic chemotherapy using oral tegafur-uracil and cyclophosphamide for recurrent gynecological cancersadvance and recurrent gynecological cancerJPRN-UMIN000016438Saitama Medical University International Medical Center30
进行中（未招募）
不适用
Study pilot of metronomic chemotherapy with ciclofosfamide, celecoxib and desametasone in patients with diagnosis of carcinoma of the refractory ormon prostate in advanced stage appraisal pharmacodynamics - PROMETORMONO REFRACTORY CARCINOMA OF PROSTATE IN ADVANCED STAGEMedDRA version: 6.1Level: PTClassification code 10007280EUCTR2005-005967-27-ITAZIENDA USL 6 LIVORNO ZONA LIVORNESE27